2nd Annual Life Science Digital Transformation Conference

May 19-20, 2020 | Chicago, IL
=

DAY ONE |TUESDAY, MAY 19

8:00 REGISTRATION & WELCOME COFFEE

 

8:45 CHAIRPERSON’S OPENING REMARKS

 

9:00 KEYNOTE PANEL: DIGITAL TRANSFORMATION IMPACT ON LIFE SCIENCE ORGANIZATIONS & FORECAST OF FUTURE TRENDS

  • Value of digital transformation across industries
  • Opportunities & limitations in the application to life science
  • Focus on building a digital bridge with the consumer
  • Outlook into the future of digital transformation

MODERATOR:
Shaheen Lakhan, THE LEARNING CORP

PANELISTS:
Nishtha Gupta, GLAXOSMITHKLINE
Michael Song, ASTRAZENECA
Charles Wolfus, ALECTOR

 

9:45 DIGITAL TRANSFORMATION JOURNEY MAPPING & STRATEGY DEPLOYMENT
With the increasing excitement and focus on optimizing corporate goals via digital technology and culture, life science organizations are at diverse levels of advancement in shifting towards new goals. As a critical first step, the organization must clearly identify distinct areas of operation to propel into the digital era, and whether a company-wide or team-specific approach is preferable. To ensure cost and time-efficiency in the execution of the digital strategy, professionals must design a comprehensive plan of action, encompassing involved human resources, realistic timelines and continuous strategy optimization efforts.

PART ONE: DEFINING INITIAL ORGANIZATIONAL NEEDS FOR STREAMLINED DIGITAL TRANSITION

  • Determining the digital strategy purpose and focus
  • Outlining team-specific needs within the organization
  • Matching corporate goals with relevant technology

Kenneth Tubman, Lead, Connected & Software Devices, TAKEDA

 

10:15 COFFEE & NETWORKING BREAK

 

10:45 PART TWO: BREAKOUT DISCUSSION – PRACTICAL APPROACHES TO OPTIMIZING DIGITAL STRATEGY EXECUTION

  • Strategic workforce and expenditure planning
  • Benchmarking strategy execution timelines
  • Methods to continuously optimize operations

Kenneth Tubman, TAKEDA
Girish Srinivasan, PHENOMX, INC.

 

11:15 PANEL: COMPARING VIEWS ON OPTIMAL TEAM AND LEADERSHIP DESIGN

  • Debating the value and structure of a transformation team
  • Establishing digital leadership and organizational placement
  • Empowering the workforce to promote creativity and flexibility
  • Fostering employee skills and growth for upgrading processes
  • Evaluation of essential profile attributes for building agile teams

Melissa Saw, BAYER
Robert Derricotte, AMBLYOTECH
Digant Gupta, APPLIED MEDICAL
Mark Towne, AVANIR PHARMACEUTICALS

 

12:00 LUNCHEON FOR ALL SPEAKERS, SPONSORS & ATTENDEES

 

1:00 PANEL: OPTIMIZING DIGITAL TRANSFORMATION VIA STRATEGIC PARTNERSHIP WITH TECHNOLOGY VENDORS

  • Defining transformation needs and applicable technology
  • Vendor selection criteria and partnership assessment
  • Ensuring aligned goals between the corporation and vendor
  • Ongoing partnership in technology optimization

Pranay Sinha, ORTHO CLINICAL DIAGNOSTICS
Melissa Saw, BAYER
Mark Summers, SANOFI
Dustin Johnson, AVANOS MEDICAL

 

1:45 INDUSTRY CASE STUDY – GENERATING GREATER PATIENT CONNECTIVITY THROUGH DIGITAL ENGAGEMENT

  • Development of digital patient engagement strategy
  • Varied methods & channels of digital patient engagement
  • Data collection, analysis & perspective on consumer privacy
  • Challenges encountered & overcome in digital connections

Amir Lahav, Digital Transformation Consultant, FORMERLY AT PFIZER

 

2:15 ANALYSIS OF TECHNOLOGIES POSITIVELY IMPACTING DIGITAL TRANSFORMATION INITIATIVES
With an ever increasing number of exciting technologies available on the market, professionals must carefully analyze opportunities and boundaries in key tools and software enabling digital transformation. Companies willing to propel operations into the digital era must also clearly outline internal needs, as well as consider whether the desired technology will prove compatible with existing systems, in addition to ease of familiarization for employees. Gaining insight into peers’ practical experience is of the highest value to digital leaders in the effort of selecting and applying promising technology to the organization.
PART ONE: INDUSTRY CASE STUDY – PRACTICAL INSIGHT INTO TECHNOLOGIES FACILITATING DIGITAL TRANSFORMATION

  • Identifying the exact need within the corporation
  • Technology selection criteria within a crowded market
  • Practical steps in applying new technologies
  • Current status of the outcomes of digitalization

Nishtha Gupta, Digital R&D Business & Technology Consultant, GLAXOSMITHKLINE

 

2:45 PART TWO: TECH TALKS: SHARING PERSPECTIVES ON DIGITAL TECHNOLOGIES
Participants will gather in moderated small groups to share experiences with existing software and technologies to gain clarity on solutions to digital problems that are changing the landscape of transformation through AI, ML, mobile technology, predictive analytics and more.

GROUP 1 – Artificial Intelligence & Machine Learning
Nishtha Gupta, GSK

GROUP 2 – Mobile Technology & Apps
Digant Gupta, APPLIED MEDICAL

GROUP 3 – Wearable Technology
Mark Towne, AVANIR PHARMACEUTICALS

 

3:15 COFFEE & NETWORKING BREAK

 

3:45 BREAKOUT DISCUSSION: EXPANDING DIGITAL INITIATIVES INTO DISTINCT CORPORATE TEAMS
With digital initiatives developing rapidly and expanding across teams within life science organizations, it is necessary to deeply explore how to effectively apply promising technology to diverse departments and ultimately optimize operations. Digitally transforming manufacturing processes, clinical affairs or commercial and marketing activities however present specific challenges to be considered upfront in order to efficiently develop a robust strategy and lead the project to successful completion. This session enables peer-to-peer exchange of practical information and lessons learned focused on leading digital endeavors within a distinct function, through facilitated small group discussions for the audience to select and actively participate in.

GROUP 1: Clinical
Nishtha Gupta, GLAXOSMITHKLINE

GROUP 2: Commercial & Marketing
Pranay Sinha, ORTHO-CLINICAL DIAGNOSTICS

 

4:15 PANEL – RATIONALE FOR UNVEILING PATIENT EXPERIENCE VIA DIGITAL MEANS

  • Outlining the “consumer experience” in pharma
  • Rationale for optimization via digital means
  • Applying user-experience and behavior analytics
  • Consumer knowledge strategies from other industries

MODERATOR:
Amir Lahav, FORMERLY AT PFIZER

PANELISTS:
Pranay Sinha, ORTHO-CLINICAL DIAGNOSTICS
Michael Song, ASTRAZENECA
Mark Towne, AVANIR PHARMACEUTICALS
Girish Srinivasan, PHENOMX, INC.

 

5:00 CLOSING REMARKS & DAY 1 CONCLUSION

 

6:00 CONTINUED NETWORKING: FACILITATED GROUP DINNERS
With the immense value in peer-to-peer interaction and experience sharing, we wish to provide attendees with an opportunity to continue networking after the first day of the conference. Q1 Productions will arrange dinner reservations at local restaurants close to the conference hotel for those interested in joining a group of fellow participants for dinner on May 19th. Please note that dinner expenses must be covered by each participant individually.

Share This